Single-ascending Dose Study of Kylo-11 in Healthy Subjects

Clinical trial NCT06363851 · COMPLETED

Trial details

NCT number: NCT06363851
Sponsor: Kylonova (Xiamen) Biopharma co., LTD.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cardiovascular Diseases

Start date: 2024-05-16
Primary completion: 2025-06-17
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.